These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3884345)
1. SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors. Ohlstein EH; Berkowitz BA Eur J Pharmacol; 1985 Jan; 108(2):205-8. PubMed ID: 3884345 [TBL] [Abstract][Full Text] [Related]
2. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393. Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro. Edwards RM Eur J Pharmacol; 1986 Jul; 126(1-2):167-70. PubMed ID: 2875883 [TBL] [Abstract][Full Text] [Related]
4. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat. Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375 [TBL] [Abstract][Full Text] [Related]
5. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319. O'Boyle KM; Waddington JL Eur J Pharmacol; 1984 Oct; 106(1):219-20. PubMed ID: 6241567 [No Abstract] [Full Text] [Related]
6. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822. Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023 [TBL] [Abstract][Full Text] [Related]
7. Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526. Ohlstein EH; Zabko-Potapovich B; Berkowitz BA J Pharmacol Exp Ther; 1984 May; 229(2):433-9. PubMed ID: 6143817 [TBL] [Abstract][Full Text] [Related]
8. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements. Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482 [TBL] [Abstract][Full Text] [Related]
9. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors. Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937 [TBL] [Abstract][Full Text] [Related]
10. Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 and SCH 23390. O'Boyle KM; Waddington JL Eur J Pharmacol; 1985 Sep; 115(2-3):291-5. PubMed ID: 2866103 [TBL] [Abstract][Full Text] [Related]
13. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Arnt J; Hyttel J; Perregaard J Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991 [TBL] [Abstract][Full Text] [Related]
14. Peripheral dopamine receptor blockade by SCH 23390 and domperidone in vitro. Hilditch A; Drew GM Eur J Pharmacol; 1985 Oct; 116(1-2):171-4. PubMed ID: 2865160 [TBL] [Abstract][Full Text] [Related]
15. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats. Arnt J Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283 [TBL] [Abstract][Full Text] [Related]
16. A study on the contribution of the 1-phenyl substituent to the molecular electrostatic potentials of some benzazepines in relation to selective dopamine D-1 receptor activity. Pettersson I; Gundertofte K; Palm J; Liljefors T J Med Chem; 1992 Feb; 35(3):502-7. PubMed ID: 1531365 [TBL] [Abstract][Full Text] [Related]
17. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390. O'Boyle KM; Waddington JL Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559 [TBL] [Abstract][Full Text] [Related]
18. The enantiomers of SK&F 83566, a new selective D-1 dopamine antagonist, stereospecifically block stereotyped behaviour induced by apomorphine and by the selective D-2 agonist RU 24213. Molloy AG; Waddington JL Eur J Pharmacol; 1985 Oct; 116(1-2):183-6. PubMed ID: 4054213 [TBL] [Abstract][Full Text] [Related]
19. Neuroinhibitory effects of SK&F 85174, a novel dopamine receptor agonist. Blumberg AL; Wilson JW; Hieble JP J Cardiovasc Pharmacol; 1985; 7(4):723-32. PubMed ID: 2410714 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors. Hieble JP; Sulpizio AC; Nichols AJ; Willette RN; Ruffolo RR J Pharmacol Exp Ther; 1988 Nov; 247(2):645-52. PubMed ID: 2903236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]